Clearmind Medicine sets USD 1 conversion price for USD 696,079.50 in notes into common shares
CMND•Shares to be issued
The conversion will be settled in common shares equal to the converted amount divided by $1, rounded under the notes’ terms. The conversion shares are registered for resale under an effective SEC registration statement, with issuance required without restrictive legends.
Notes and amendment details
The notes were originally issued under a September 17, 2025 securities purchase agreement, later amended on April 30, 2026. The company amended the notes’ Floor Price definition to $1 for this conversion.
Conversion price set for outstanding notes
Clearmind set a $1 per-share conversion price for outstanding convertible notes totaling USD 696,079.50, overriding the notes’ conversion formula.
